Skip to content
10-Q

Quarterly Report

Sionna Therapeutics, Inc. SION

0002036042-25-000016

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 1, 2025 44.12M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $9.53M
Current Liabilities Q1 2025 · Dec 31, 2024 $10.42M
Total Liabilities Q1 2025 · Mar 31, 2025 $17.91M
Total Liabilities Q1 2025 · Dec 31, 2024 $19.1M
Current Assets Q1 2025 · Mar 31, 2025 $273.68M
Current Assets Q1 2025 · Dec 31, 2024 $150.99M
Total Assets Q1 2025 · Mar 31, 2025 $369.67M
Total Assets Q1 2025 · Dec 31, 2024 $185.75M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $37.79M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $82.75M
Shares Diluted Q1 2025 · Mar 31, 2024 3.08M sh
Capex Q1 2025 · Mar 31, 2024 $0
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$13.18M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$126.08M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$114.88M
Eps Diluted Q1 2025 · Mar 31, 2024 −$3,840.00
Eps Basic Q1 2025 · Mar 31, 2024 −$3,840.00
Sga Expense Q1 2025 · Mar 31, 2024 $2.93M
Rd Expense Q1 2025 · Mar 31, 2024 $10.22M
Net Income Q1 2025 · Mar 31, 2024 −$11.85M
Operating Income Q1 2025 · Mar 31, 2024 −$13.15M